🇺🇸 tetrahydrocannabinol in United States

1,770 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Toxicity To Various Agents — 412 reports (23.28%)
  2. Drug Abuse — 300 reports (16.95%)
  3. Overdose — 182 reports (10.28%)
  4. Vomiting — 156 reports (8.81%)
  5. Drug Interaction — 153 reports (8.64%)
  6. Dizziness — 123 reports (6.95%)
  7. Anxiety — 122 reports (6.89%)
  8. Nausea — 120 reports (6.78%)
  9. Tremor — 102 reports (5.76%)
  10. Dyspnoea — 100 reports (5.65%)

Source database →

Other Metabolic approved in United States

Frequently asked questions

Is tetrahydrocannabinol approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for tetrahydrocannabinol in United States?

Wageningen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.